G protein diseases: Newly recognized causes of metabolic encephalopathy

European Journal of Paediatric Neurology

Volumn 7, Issue 5, 2003, Pages 211-215

  Jaeken, Jaak C ^a   Freson, Kathleen ^a   Goemans, Nathalie M ^a   De Cock, Paul P ^a   De Vos, Rita M ^a   Lagae, Lieven G ^a   Van Geet, Christel A ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTATE AMINOTRANSFERASE; CARBAMAZEPINE; CREATINE KINASE; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE DIPHOSPHATE; HORMONE RECEPTOR; LACTATE DEHYDROGENASE; NEUROLEPTIC AGENT; NEUROTRANSMITTER RECEPTOR; RISPERIDONE;

ARTICLE; BEHAVIOR DISORDER; BIRTH WEIGHT; BLEEDING TIME; CASE REPORT; CHEMICAL ANALYSIS; CLINICAL FEATURE; ENZYME ACTIVITY; FEMALE; GENE MUTATION; GENERALIZED EPILEPSY; GROWTH RETARDATION; HEAD CIRCUMFERENCE; HUMAN; MALE; METABOLIC ENCEPHALOPATHY; MUSCLE HYPOTONIA; NEUROLOGIC DISEASE; NEUROLOGIC EXAMINATION; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN POLYMORPHISM; SIGNAL TRANSDUCTION; SYMPTOMATOLOGY; URINALYSIS;

EID: 0141954897     PISSN: 10903798     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1090-3798(03)00102-8     Document Type: Article

References (14)

1. Farfel Z, Bourne HR, Iiri T. The expanding spectrum of G protein diseases. N Engl J Med 1999;340:1012-9.
2. Spiegel AM. G protein defects in signal transduction. Horm Res 2000;53:17-22.
3. Hayward BE, Moran V, Strain L, Bonthron DT. Bidirectional imprinting of a single gene: GNAS1 encodes maternally, paternally, and biallelically derived proteins. Proc Natl Acad Sci USA 1998;95:15475-80.
4. Ischia R, Lorisetti-Scamihorn P, Hogue-Angeletti R, et al. Molecular cloning and characterization of NESP55, a novel chromogranin-like precursor of a peptide with 5-HT1B receptor antagonist activity. J Biol Chem 1997;272: 11657-62.
5. Kehlenbach RH, Matthey J, Huttner WB. XL alpha s is a new type of G protein. Nature 1994;372:804-9.
6. Pasolli HA, Klemke M, Kehlenbach RH, Wang Y, Huttner WB. Characterization of the extra-large G-protein α-subunit XLαs. I. Tissue distribution and subcellular localization. J Biol Chem 2000;275:33622-32.
7. Bastepe M, Gunes Y, Perez-Vittamil B, et al. Receptor-mediated adenytyl cyclase activation through XLα-s, the extra-large variant of the stimulatory G protein α-subunit. Mol Endocrinol 2002;16:1912-9.
8. Klemke M, Kehlenbach RH, Huttner WB. Two overlapping reading frames in a single exon encode interacting proteins-a novel way of gene usage. EMBO J 2001;20: 3849-60.
9. s hyperfunction in platelets and is a risk factor for bleeding. Thromb Haemost 2001;86:733-8.
10. Freson K, Jaeken J, Van Helvoirt M, et al. Functional polymorphisms in the paternally expressed XLαs and its cofactor ALEX decrease their mutual interaction and enhance receptor-mediated cAMP formation. Hum Mol Genet 2003;12:1121-30.
11. 3 subunit gene (GNB3) with arterial hypertension but not with myocardial infarction. Cardiovasc Res 2001;49:820-7.
12. Jaeken J, Freson K, Hoylaerts M, et al. Signal transduction defects: a novel family of neurometabolic diseases. J Inherit Metab Dis 2000;23(Suppl. 1):205.
13. 3 subunit variant with hypertension. Nat Genet 1998;18:45-8.
14. Schor NF. Signal transduction for clinicians: why should we care? Pediatr Neurol 2001;25:361-7.